clofarabine has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 1 studies
Studies (clofarabine) | Trials (clofarabine) | Recent Studies (post-2010) (clofarabine) | Studies (benzyloxycarbonylleucyl-leucyl-leucine aldehyde) | Trials (benzyloxycarbonylleucyl-leucyl-leucine aldehyde) | Recent Studies (post-2010) (benzyloxycarbonylleucyl-leucyl-leucine aldehyde) |
---|---|---|---|---|---|
424 | 101 | 280 | 2,473 | 3 | 1,057 |
Protein | Taxonomy | clofarabine (IC50) | benzyloxycarbonylleucyl-leucyl-leucine aldehyde (IC50) |
---|---|---|---|
Proteasome subunit beta type-11 | Homo sapiens (human) | 1.9893 | |
Calpain-9 | Homo sapiens (human) | 9.88 | |
Proteasome subunit alpha type-7 | Homo sapiens (human) | 1.9893 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 3.9 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.8999 | |
Aromatase | Homo sapiens (human) | 0.044 | |
Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 0.5 | |
Proteasome subunit beta type-1 | Homo sapiens (human) | 1.0853 | |
Proteasome subunit alpha type-1 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit alpha type-2 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit alpha type-3 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit alpha type-4 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-8 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-9 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit alpha type-5 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-4 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-6 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-5 | Homo sapiens (human) | 0.6088 | |
Proteasome subunit beta type-10 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-3 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-2 | Homo sapiens (human) | 2.0443 | |
Proteasome subunit alpha type-6 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit alpha-type 8 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-7 | Homo sapiens (human) | 1.9893 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, YJ; Hwang, IS; Kim, SH; Lee, CH; Lee, SH; Lee, YJ; Nam, HS | 1 |
1 other study(ies) available for clofarabine and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
Article | Year |
---|---|
Knockdown of Bcl-xL enhances growth-inhibiting and apoptosis-inducing effects of resveratrol and clofarabine in malignant mesothelioma H-2452 cells.
Topics: Adenine Nucleotides; Antimetabolites, Antineoplastic; Apoptosis; Arabinonucleosides; bcl-X Protein; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Proliferation; Clofarabine; G2 Phase Cell Cycle Checkpoints; Gene Knockdown Techniques; Humans; Leupeptins; Lung Neoplasms; M Phase Cell Cycle Checkpoints; Mesothelioma; Mesothelioma, Malignant; Myeloid Cell Leukemia Sequence 1 Protein; Resveratrol; RNA Interference; RNA, Messenger; RNA, Small Interfering; Stilbenes | 2014 |